Sagimet Biosciences (SGMT) announced the appointments of two biotechnology industry leaders, Anne Phillips and Jennifer Jarrett, to the board of directors of the Company, effective August 1, 2024. Philips joins Sagimet’s board following an 11 year tenure as corporate and senior vice president of clinical, medical, and regulatory affairs at Novo Nordisk (NVO). Jarrett has served as chief operating officer of Arcus Biosciences (RCUS) for the last four years
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SGMT:
- Sagimet Biosciences Announces Appointment of Anne Phillips and Jennifer Jarrett to its Board of Directors
- Sagimet Biosciences participates in a conference call with Piper Sandler
- Sagimet Biosciences downgraded to Neutral from Buy at Goldman Sachs
- Sagimet Biosciences to hold a conference call
- Sagimet Biosciences to Host Conference Call and Webcast to Discuss Recently Presented Data from ITT and F3 Patient Population in Phase 2b FASCINATE-2 Clinical Trial of Denifanstat